Seeing Is Believing
Healthcare - Sector
RYTM is currently covered by 13 analysts with an average price target of $116.94. This is a potential upside of $29.56 (33.83%) from yesterday's end of day stock price of $87.38.
Rhythm Pharmaceuticals's activity chart (see below) currently has 161 price targets and 168 ratings on display. The stock rating distribution of RYTM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 80.48% with an average time for these price targets to be met of 316.83 days.
Highest price target for RYTM is $176, Lowest price target is $80, average price target is $132.31.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 12-Mar-2026. First documented stock forecast 30-Oct-2017.
Currently out of the existing stock ratings of RYTM, 57 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Jul-2019
$143
$55.62 (63.65%)
$136
3 days ago
(12-Mar-2026)
12/17 (70.59%)
$51.85 (56.88%)
342
Buy Since 21-Oct-2024
$143
$55.62 (63.65%)
$140
13 days ago
(02-Mar-2026)
1/6 (16.67%)
$50.27 (54.21%)
261
Buy Since 17-Sep-2024
$176
$88.62 (101.42%)
$167
13 days ago
(02-Mar-2026)
4/10 (40%)
$83.27 (89.80%)
97
Buy Since 18-Sep-2024
$110
$22.62 (25.89%)
$125
13 days ago
(02-Mar-2026)
12/15 (80%)
$17.27 (18.62%)
112
Buy Since 02-Mar-2023
$140
$52.62 (60.22%)
$141
13 days ago
(02-Mar-2026)
10/12 (83.33%)
$47.27 (50.98%)
302
What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RYTM (Rhythm Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?
Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?
Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?